|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | BCLC策略:预后预测和治疗推荐2022版更新显示文摘2018版BCLC预后和治疗推荐策略发布后,肝细胞癌(简称HCC)的研究又取得了重大进展。本次更新基于肝癌各领域的研究进展结果。重点关注影响策略的重要研究进展。虽然近年的研究结果成绩斐然,但将其引入为临床医生和研究者提供行动依据的循证模型指南来说证据效力依然不够确切。本文对该问题进行分析,阐述了为HCC患者制定个体化治疗临床决策所需的批判性思维和专业知识。 | Reig M Forner A Rimola J Ferrer-Fabrega J Burrel M Garcia-Criado A Kelley RK Galle PR Mazzaferro V Salem R Sangro B Singal AG Vogel A Fuster J Ayuso C Bruix J 刘永凡(摘译) 崔笑(摘译) 耿小平(审校) | 2022 | 肝胆外科杂志2022，30，5： | 80 |
| 2 | 在没有危险因素的情况下,正常的低密度脂蛋白胆固醇水平与亚临床动脉粥样硬化相关显示文摘普遍认为缺乏心血管病危险因素(cardiovascular risk factors,CVRF)人群的动脉粥样硬化发生风险低,然而,无CVRF的个体仍然有心血管事件发生。为了确定无CVRF个体中亚临床动脉粥样硬化的预测因子, | Fernández-Friera L Fuster V López-Melgar B Oliva B García-Ruiz JM Mendiguren J Bueno H Pocock S Ibánez B Fernández-Ortiz A Sanz J 刘莉 叶鹏 | 2017 | 中华高血压杂志2017，25，12： | 17 |
| 3 | Atheroscl~rotic plaque rup- ture2 and thro~si,显示文摘 | Fuster V Stein B Ambrose JA | 1990 | Evolving Concepts Circulation1990，82，： | 1 |
| 4 | Imaging subclinical atherosclerosis:is it ready for prime time? A review显示文摘 | Fernfindez -Friera L Ibanez B and Fuster V | 2014 | J Cardiovasc Transl Res2014，7，： | 1 |
| 5 | Platelet inhibitor agents in cardiovascular disease: an update显示文摘 | Stein B Fuster V Israel DH | 1989 | J Am Coll Cardiol1989，14，： | 1 |
| 6 | ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text:a report of the American College of Cardiology/A- merican Heart Association Task Force on practice guide- lines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society 显示文摘 | Fuster V Ryd6n L E Cannom D S Crijns H J Curtis A B Ellenbogen K A | 2006 | Europace2006，8，： | 1 |
| 7 | Attentional Biases and Vulnerability to Depression显示文摘 | Perez M G Barnos Rivera R M Fuster A B | 1999 | Spanish Journal of Psychology1999，2，1： | 1 |
| 8 | Select clinical trials of erlotinib (OSI2 774) in non-small-cell lung cancer with emphasis on phase III out comes 显示文摘 | Fuster L M Sandier A B | 2004 | Clin Lung Cancer2004，6，1： | 1 |
| 9 | Atherosclerotic plaque rupture and thrombosis:evolving concepts显示文摘 | Stein B Badiman JJ | 1990 | Circulation1990，82，2： | 1 |
| 10 | Attentional Bias sand Vulnerability to Depression显示文摘 | Perez M G Banos Rivera R M Fuster A B et a1 | 1999 | Spanish Journal of Psychology1999，2，1： | 1 |
| 11 | Intracellular cytokine pro- file of T lymphocytes in patients with chronic obstructive pul- monary disease显示文摘 | Barcelo B Pons J Fuster A | 2006 | Clin Exp Immunol2006，145，3： | 1 |
| 12 | Modulation of the beta-adrenergic system during acute myocardial in- farction: rationale for a new clinical trial显示文摘 | Ibdaez B Fuster V Macaya C | 2011 | Rev Esp Cardiol2011，64，2： | 1 |
| 13 | Global perspective onacute coronary syndrome; a burden on the young and poor显示文摘 | Vedanthan R Seligman B Fuster V | 2014 | Circ Res2014，114，19： | 1 |
| 14 | Modulation of the beta-adrenergic system during acute myocardial infarction:rationale for a new clinical trial显示文摘 | Ibáfnez B Fuster V Macaya C | 2011 | Rev Esp Cardiol2011，64，2： | 1 |
| 15 | Bleeding com- plications with dual antiplatelet therapy among patients with sta- ble vascular disease or risk factors for vascular disease:results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance ( CHARISMA ) trial 显示文摘 | BERGER P B BHATT D L FUSTER V | 2010 | Circulation2010，121，23： | 1 |
| 16 | The natural history of idio- pathic dilated cardiomyopathy显示文摘 | Fuster B Gersh BJ Guiliani ER | 1981 | Am J Cardiol1981，47，： | 1 |
| 17 | Recognizing Global Burden of Cardiovascular Disease and Related Chronic Diseases显示文摘 | KELLY BRIDGET B NARULA JAGAT FUSTER VALENTíN | 2012 | The Mount Sinai Journal of Medicine2012，79，6： | 1 |
| 18 | ACC/AHA 2005 Guideline Update for the Di- agnosis and Management of Chronic Heart Failure in the Adult: a re- port of the American College of Cardiology/American Heart Associa- tion Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society 显示文摘 | Hunt SA Abraham WT Chin MH Feldman AM Francis GS Ganiats TG Jessup M Konstam MA Mancini DM Michl K Oates JA Rahko PS Silver MA Stevenson LW Yancy CW Antman EM Smith SC Jr Adams CD Anderson JL Faxon DP Fuster V Halperin JL Hiratzka LF Jacobs AK Nishimura R Or nato JP Page RL Riegel B American College of Cardiology American Heart Associa- tion Task Force on Practice Guidelines American College of Chest Physicians International Society for Heart and Lung Transplantation Heart Rhythm Society | 2005 | Circula- tion2005，112，12： | 1 |
| 19 | Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease显示文摘 | Barcel B Pons J Fuster A | 2006 | Clin Exp Immunol2006，145，3： | 1 |
| 20 | Atherosclerotic plaque ruptureand thrombosis显示文摘 | Fuster V Stein B Ambrose JA | 1990 | Evolving Concepts Circulation1990，82，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员